Drug Channels

DECEMBER 5, 2023

The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. Below, I walk through the economic fundamentals to help you understand another obscure aspect of our opaque drug pricing system. to 1:30 p.m.

Drug Pricing 84

Drug Pricing Hospitals 84

Drug Channels

FEBRUARY 27, 2024

In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency? Sorry, no Threads.) All rights reserved.

Drug Pricing 69

Drug Pricing 69

Drug Channels

SEPTEMBER 13, 2021

Informa Connect’s Drug Pricing Transparency Congress. Delivered as a Hybrid Event In-Person: November 9-10 | Philadelphia, PA Virtual: November 16-17 www.informaconnect.com/drug-pricing-transparency. Drug Channels, or any of its employees. Copyright © 2006-2021 Pembroke Consulting, Inc.

Drug Pricing 58

Drug Pricing 58

Drug Channels

APRIL 5, 2024

Thanks to the IRA, Part D Plans Will Prefer High-List, High-Rebate Drugs. It's time for Drug Channels ’ annual reality check on U.S. drug pricing. For 2023, brand-name drugs’ list prices again grew at mid-single-digit rates. However, net prices dropped for an unprecedented sixth consecutive year.

Drug Pricing 68

Drug Pricing 68

Drug Channels

FEBRUARY 7, 2024

And contrary to what you might read, drug spending growth was *not* driven by purportedly “skyrocketing” drug prices. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures. healthcare expenditures.

Drug Pricing 93

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 93

Drug Channels

JANUARY 5, 2021

It was another year of unexpected drug price developments. In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. I also review the factors behind declining brand-name drug prices.

Drug Pricing 52

Drug Pricing 52

Drug Channels

MARCH 5, 2021

Edward discusses the impact of providing access to drug price transparency and affordability programs to healthcare providers and patients at the point of care. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. To learn more about AssistRx’s solutions, visit AssistRx.com.

Drug Pricing 52

Drug Pricing 52

Drug Channels

JULY 12, 2024

Gavin discusses the three key reasons for duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He then explains Oregon’s novel approach to fixing the problem.

Drug Pricing 94

Drug Pricing 94

Drug Channels

JUNE 22, 2022

See The GoodRx-Kroger Blowup: Spread Pricing, Pharmacy Margins, and the Future of Discount Cards. In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business. d/b/a Drug Channels Institute.

Drug Pricing 58

Drug Pricing 58

Drug Channels

MARCH 23, 2021

It was another year of unexpected drug price developments. In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. I also review the factors behind declining brand-name drug prices.

Drug Pricing 52

Drug Pricing 52

Drug Channels

MAY 10, 2022

When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs to less than half of their list prices. That’s why I refer to them as drug pricing flat earthers (#DPFE).

Drug Pricing 91

Drug Pricing Pharmaceutical Manufacturing 91

Drug Channels

DECEMBER 8, 2020

When Americans complains about “drug prices,” most are actually complaining about the share of costs they pay—and how those costs are computed. drug channel. Today, I review four crucial issues that the new Congress could tackle to address affordability, patients' out-of-pocket obligations, and prescription prices.

Drug Pricing 52

Drug Pricing 52

Drug Channels

MARCH 25, 2021

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. When Americans complain about “drug prices,” most are actually complaining about the share of costs they pay—and how those costs are computed. drug channel.

Drug Pricing 52

Drug Pricing 52

Drug Channels

JULY 28, 2022

When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs to less than half of their list prices. That’s why I refer to them as drug pricing flat earthers (#DPFE).

Drug Pricing 89

Drug Pricing Pharmaceutical Manufacturing 89

Drug Channels

JUNE 14, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. As Nobel prize winner Ronald Coase observed: “If you torture the data long enough, it will confess to anything.” Read on and consider what the data are really saying.

Drug Pricing 81

Drug Pricing 81

Drug Channels

AUGUST 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.

Drug Pricing 72

Drug Pricing Hospitals 72

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.

Drug Pricing 52

Drug Pricing 52

Drug Channels

MARCH 21, 2024

How will the most consequential change in federal drug pricing policy affect drug pricing? Find out during Drug Channel Implications of the Inflation Reduction Act , a new live video webinar with Adam J. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Drug Pricing 75

Drug Pricing 75

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. How will the most consequential change in federal drug pricing policy affect the largest pharmacies and PBMs? Pharmacies and Pharmacy Benefit Managers. to 1:30 p.m.

Drug Pricing 81

Drug Pricing 81

Drug Channels

SEPTEMBER 30, 2020

We’ve been squirrelling away these acorns from the mighty Drug Channels oaks: I agree. Brand-name drugs prices keep on dropping It’s official: CVS Health’s Zinc GPO actually exists! Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Autumn is here! You can also join my 23.3K

Drug Pricing 52

Drug Pricing 52

Drug Channels

SEPTEMBER 28, 2021

Curl up with your favorite pumpkin-spiced blog and savor these stories harvested from the Drug Channels patch: Fresh insights about hospitals’ specialty drug profits SSR Update: Drug prices keep dropping My $0.02 Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drug Pricing 56

Drug Pricing Hospitals Biosimilars 56

Drug Channels

APRIL 1, 2024

Below, I walk through the economic fundamentals to help you understand another obscure aspect of our opaque drug pricing system. Tomorrow on Drug Channels , I’ll delve into the pros and cons of this new approach. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Drug Pricing 87

Drug Pricing Hospitals 87

Drug Channels

OCTOBER 4, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs at the biggest drugmakers to less than half of their list prices.

Drug Pricing 87

Drug Pricing Pharmaceutical Manufacturing 87

Drug Channels

NOVEMBER 25, 2024

drug prices really higher than other countries? Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. Plus, Dr. Glaucomflecken gets us ready for the open enrollment season.

Drug Pricing 59

Drug Pricing 59

Drug Channels

OCTOBER 12, 2020

Informa Connect-CBI’s 6th Edition Drug Pricing Transparency Congress. November 16-17, 2020 | Virtual Event www.informaconnect.com/drug-pricing-transparency. Drug Channels Readers: View the complete agenda and register today. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Drug Pricing 40

Drug Pricing 40

Drug Channels

JUNE 4, 2024

Find out during The 340B Drug Pricing Program: Trends, Controversies, and Outlook , a new live video webinar with Adam J. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Full salary and employment data below for your enjoyment or sorrow.

Hospitals 80

Hospitals Physician Offices Drug Pricing 80

Drug Channels

SEPTEMBER 29, 2023

According to Kalderos, at least 5% of commercial rebates are paid for prescriptions that also have discounts under the 340B Drug Pricing Program. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Drug Pricing 81

Drug Pricing 81

Drug Channels

AUGUST 15, 2022

Here’s a summer surprise for fans of the 340B Drug Pricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. The data tell a familiar story.

Hospitals 92

Hospitals Drug Pricing 92

Drug Channels

NOVEMBER 8, 2022

drug channel, the roles and controversies around pharmacy benefit managers (PBMs), GoodRx, Mark Cuban’s cost-plus pharmacy, the 340B Drug Pricing Program, and much more. P.S. Let me know if you’d like to see more audio/podcast content on Drug Channels. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Drug Pricing 81

Drug Pricing 81

Drug Channels

JUNE 21, 2024

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. I found Mark’s comments to be intriguing and highly provocative, so I invited him to publish an edited version exclusively here on Drug Channels. All rights reserved.

Drug Pricing 73

Drug Pricing 73

Drug Channels

JUNE 1, 2023

Vishali discusses the persistent challenges of duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. To learn more, sign up now for priority access to Kalderos’ 2023 annual report: Mission Critical: Bringing Drug Discount Stakeholders Together so Patients Win.

Drug Pricing 75

Drug Pricing 75

Drug Channels

JULY 5, 2022

Read on for full details on pricing and registration. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Fein will clearly distinguish his opinions and interpretations from the objective facts and data.

Drug Pricing 85

Drug Pricing 85

Drug Channels

JUNE 13, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs at the biggest drugmakers to less than half of their list prices.

Drug Pricing 81

Drug Pricing Pharmaceutical Manufacturing 81

Drug Channels

DECEMBER 15, 2023

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. The difference between list prices and discounted 340B purchases also grew, to $52.3 Every 340B covered entity type experienced double-digit growth, despite drug prices that grew more slowly than overall inflation.

Drug Pricing 81

Drug Pricing Hospitals 81

Drug Channels

MARCH 8, 2022

Next week, Drug Channels Institute will release our 2022 Economic Report on U.S. It’s the 13th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before March 28, 2022. d/b/a Drug Channels Institute.

Drug Pricing 86

Drug Pricing 86

Safe Biologics

OCTOBER 10, 2023

ASBM Statement on Announcement of Medicare Drug Price-Setting List On August 29th, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 drugs selected under its Medicare drug price “negotiation” plan, authorized by the Inflation Reduction Act (IRA) signed into law last year.

Biosimilars 130

Biosimilars Drug Pricing Drug Development 130

Drug Channels

APRIL 18, 2023

Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program. The IRA will alter many crucial aspects of the Medicare program and the overall drug channel. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drug Pricing 67

Drug Pricing 67